(RYAM) Rayonier Advanced Materials - Ratings and Ratios
Cellulose, Plastics, Textiles, Paperboard, Pulp
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 51.5% |
| Value at Risk 5%th | 75.5% |
| Relative Tail Risk | -10.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.43 |
| Alpha | -43.94 |
| CAGR/Max DD | -0.14 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.484 |
| Beta | 1.211 |
| Beta Downside | 1.563 |
| Drawdowns 3y | |
|---|---|
| Max DD | 71.59% |
| Mean DD | 43.04% |
| Median DD | 45.10% |
Description: RYAM Rayonier Advanced Materials October 27, 2025
Rayonier Advanced Materials (RYAM) produces and markets a broad portfolio of cellulose-based specialty and commodity products across six geographic regions. Its operations are organized into three segments-High Purity Cellulose, Paperboard, and High-Yield Pulp-supplying natural polymers for applications ranging from LCD panels, impact-resistant plastics, and pharmaceutical thickeners to rayon textiles, absorbent fluff for hygiene products, and packaging paperboards.
In FY 2023 the company generated roughly $1.2 billion in revenue with an adjusted EBITDA margin of about 12%, and it reported a backlog of ~ $200 million, indicating near-term demand strength. Key economic drivers include the accelerating shift toward sustainable packaging (which boosts paperboard volumes) and the growth of electric-vehicle tire-cord demand, while Asian pulp price volatility and logistics bottlenecks remain material cost risks. Capacity utilization across its U.S. and European plants averaged ~ 85%, suggesting limited headroom for rapid volume expansion without new investments.
If you want a deeper, data-rich assessment of RYAM’s valuation and upside potential, you may find ValueRay’s detailed model worth exploring.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-415.4m TTM) > 0 and > 6% of Revenue (6% = 88.3m TTM) |
| FCFTA -0.04 (>2.0%) and ΔFCFTA -8.68pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.57% (prev 16.26%; Δ -1.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 46.6m > Net Income -415.4m (YES >=105%, WARN >=100%) |
| Net Debt (745.2m) to EBITDA (151.1m) ratio: 4.93 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.57 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (67.0m) change vs 12m ago 1.68% (target <= -2.0% for YES) |
| Gross Margin 8.06% (prev 9.57%; Δ -1.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 74.40% (prev 75.50%; Δ -1.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.21 (EBITDA TTM 151.1m / Interest Expense TTM 95.4m) >= 6 (WARN >= 3) |
Altman Z'' 0.67
| (A) 0.12 = (Total Current Assets 590.6m - Total Current Liabilities 376.2m) / Total Assets 1.80b |
| (B) -0.04 = Retained Earnings (Balance) -67.4m / Total Assets 1.80b |
| (C) 0.01 = EBIT TTM 20.4m / Avg Total Assets 1.98b |
| (D) -0.06 = Book Value of Equity -88.8m / Total Liabilities 1.44b |
| Total Rating: 0.67 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 30.08
| 1. Piotroski 2.0pt |
| 2. FCF Yield -6.89% |
| 3. FCF Margin -5.46% |
| 4. Debt/Equity 2.43 |
| 5. Debt/Ebitda 4.93 |
| 6. ROIC - WACC (= -2.03)% |
| 7. RoE -79.79% |
| 8. Rev. Trend -33.45% |
| 9. EPS Trend -29.77% |
What is the price of RYAM shares?
Over the past week, the price has changed by -5.71%, over one month by -1.00%, over three months by -5.56% and over the past year by -26.39%.
Is RYAM a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RYAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9 | 51.5% |
| Analysts Target Price | 9 | 51.5% |
| ValueRay Target Price | 5.8 | -2.9% |
RYAM Fundamental Data Overview December 10, 2025
P/E Forward = 11.6144
P/S = 0.286
P/B = 1.2481
P/EG = -1.47
Beta = 2.174
Revenue TTM = 1.47b USD
EBIT TTM = 20.4m USD
EBITDA TTM = 151.1m USD
Long Term Debt = 763.5m USD (from longTermDebt, last quarter)
Short Term Debt = 38.5m USD (from shortTermDebt, last quarter)
Debt = 822.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 745.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.17b USD (420.8m + Debt 822.2m - CCE 77.0m)
Interest Coverage Ratio = 0.21 (Ebit TTM 20.4m / Interest Expense TTM 95.4m)
FCF Yield = -6.89% (FCF TTM -80.4m / Enterprise Value 1.17b)
FCF Margin = -5.46% (FCF TTM -80.4m / Revenue TTM 1.47b)
Net Margin = -28.23% (Net Income TTM -415.4m / Revenue TTM 1.47b)
Gross Margin = 8.06% ((Revenue TTM 1.47b - Cost of Revenue TTM 1.35b) / Revenue TTM)
Gross Margin QoQ = 9.63% (prev 6.95%)
Tobins Q-Ratio = 0.65 (Enterprise Value 1.17b / Total Assets 1.80b)
Interest Expense / Debt = 3.04% (Interest Expense 25.0m / Debt 822.2m)
Taxrate = 157.1% (out of range, set to none) (11.0m / 7.00m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.57 (Total Current Assets 590.6m / Total Current Liabilities 376.2m)
Debt / Equity = 2.43 (Debt 822.2m / totalStockholderEquity, last quarter 338.2m)
Debt / EBITDA = 4.93 (Net Debt 745.2m / EBITDA 151.1m)
Debt / FCF = -9.27 (negative FCF - burning cash) (Net Debt 745.2m / FCF TTM -80.4m)
Total Stockholder Equity = 520.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -23.13% (Net Income -415.4m / Total Assets 1.80b)
RoE = -79.79% (Net Income TTM -415.4m / Total Stockholder Equity 520.6m)
RoCE = 1.59% (EBIT 20.4m / Capital Employed (Equity 520.6m + L.T.Debt 763.5m))
RoIC = 1.52% (EBIT 20.4m / (Assets 1.80b - Curr.Liab 376.2m - Cash 77.0m))
WACC = 3.55% (E(420.8m)/V(1.24b) * Re(10.48%) + (debt cost/tax rate unavailable))
Discount Rate = 10.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.25%
Fair Price DCF = unknown (Cash Flow -80.4m)
EPS Correlation: -29.77 | EPS CAGR: 1.52% | SUE: -0.03 | # QB: 0
Revenue Correlation: -33.45 | Revenue CAGR: -1.53% | SUE: -0.91 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=+0.020 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.43 | Chg30d=+0.032 | Revisions Net=-1 | Growth EPS=+109.7% | Growth Revenue=+6.9%
Additional Sources for RYAM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle